Juvenile Myositis clinical trials at UCSF
1 research study open to eligible people
Juvenile myositis is a disease where the body's muscles swell and hurt. UCSF is researching how effective CABA-201 is for treating muscle inflammation. The study examines its effects on young people.
Showing trials for
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
open to eligible people ages 6-75
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
San Francisco, California and other locations
Our lead scientists for Juvenile Myositis research studies include Susan Kim, MD, MMSc.
Last updated: